| |
| |
| Exchange: |
N/A |
| Security
Type: |
Common |
| Shares
Out: |
118,610,000 |
| Market
Cap: |
23.41(M) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$0.1974 - $0.2749 |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Oncocyte is a molecular diagnostics company focused on developing and commercializing proprietary laboratory-developed tests to serve unmet medical needs across the cancer care continuum. Co.'s DetermaRx™ is a predictive molecular test for early-stage adenocarcinoma of the lung. This test provides information that a physician can use to help identify early-stage, surgically resected patients with Stage I and IIA non-squamous non-small cell lung cancer who are at high-risk of recurrence and may benefit from chemotherapy. Co.'s portfolio includes a gene expression-based test called DetermaIO™, which is being developed to identify patients most likely to respond to immunotherapy drugs.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
2,457,288 |
2,457,288 |
2,487,288 |
30,608,426 |
| Total Buy Value |
$7,167,688 |
$7,167,688 |
$7,174,135 |
$15,854,134 |
| Total People Bought |
3 |
3 |
4 |
10 |
| Total Buy Transactions |
4 |
4 |
5 |
20 |
| Total Shares Sold |
0 |
0 |
0 |
107,514 |
| Total Sell Value |
$0 |
$0 |
$0 |
$111,901 |
| Total People Sold |
0 |
0 |
0 |
2 |
| Total Sell Transactions |
0 |
0 |
0 |
2 |
| End Date |
2024-01-28 |
2023-10-27 |
2023-04-28 |
2022-04-28 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Arno Andrew |
Director |
– • – |
2024-04-11 |
4 |
B |
$2.95 |
$99,999 |
D/D |
33,898 |
69,054 |
2.39 |
- |
|
| Riggs Josh |
CEO and President |
• • – |
2024-04-11 |
4 |
B |
$2.95 |
$10,001 |
D/D |
3,390 |
3,505 |
2.81 |
- |
|
| Bradsher Neal C |
10% Owner |
– – • |
2024-04-11 |
4 |
B |
$0.00 |
$0 |
I/I |
0 |
4,929,066 |
1.42 |
- |
|
| Bradsher Neal C |
10% Owner |
– – • |
2024-04-11 |
4 |
B |
$2.92 |
$7,057,688 |
D/D |
2,420,000 |
4,929,066 |
2.45 |
- |
|
| Gutfreund John Peter |
Former Director |
– – – |
2023-06-30 |
4 |
D |
$0.00 |
$0 |
I/I |
(3,085,047) |
0 |
|
- |
|
| Arno Andrew |
Director |
– • – |
2023-06-23 |
4 |
A |
$0.00 |
$0 |
D/D |
30,000 |
703,133 |
|
- |
|
| Kingsley Alfred D |
Director |
– • – |
2023-06-23 |
4 |
A |
$0.00 |
$0 |
D/D |
20,000 |
489,111 |
|
- |
|
| Silverman Lou |
Director |
– • – |
2023-06-23 |
4 |
A |
$0.00 |
$0 |
D/D |
25,000 |
31,270 |
|
- |
|
| Last Andrew J. |
Director |
– • – |
2023-06-23 |
4 |
A |
$0.00 |
$0 |
D/D |
20,000 |
90,170 |
|
- |
|
| Kingsley Alfred D |
Director |
– • – |
2023-06-14 |
4 |
B |
$0.21 |
$6,447 |
D/D |
30,000 |
469,111 |
2.39 |
-10% |
|
| Kamen Efrem |
10% Owner |
– – • |
2023-04-05 |
4 |
B |
$0.30 |
$200,027 |
I/I |
663,000 |
8,090,202 |
1.5 |
-27% |
|
| Gutfreund John Peter |
Director |
– • – |
2023-04-03 |
4 |
A |
$0.35 |
$354,400 |
I/I |
1,000,000 |
1,075,000 |
|
- |
|
| Gutfreund John Peter |
Director |
– • – |
2023-04-03 |
4 |
A |
$0.35 |
$249,852 |
D/D |
705,000 |
715,000 |
|
- |
|
| Arno Andrew |
Director |
– • – |
2023-04-03 |
4 |
A |
$0.35 |
$100,000 |
I/I |
282,168 |
156,084 |
|
- |
|
| Arno Andrew |
Director |
– • – |
2023-04-03 |
4 |
A |
$0.35 |
$50,000 |
D/D |
141,084 |
673,133 |
|
- |
|
| Bradsher Neal C |
10% Owner |
– – • |
2023-04-03 |
4 |
B |
$0.00 |
$0 |
I/I |
0 |
50,181,335 |
1.42 |
-38% |
|
| Bradsher Neal C |
10% Owner |
– – • |
2023-04-03 |
4 |
B |
$0.30 |
$8,093,898 |
D/D |
26,827,638 |
50,181,335 |
2.45 |
-38% |
|
| Kamen Efrem |
10% Owner |
– – • |
2023-03-06 |
4 |
D |
$0.00 |
$0 |
I/I |
(3,890,111) |
4,589,571 |
|
- |
|
| Gutfreund John Peter |
Director |
– • – |
2022-12-23 |
4 |
B |
$0.33 |
$24,728 |
I/I |
75,000 |
75,000 |
2.1 |
-31% |
|
| Arno Andrew |
Director |
– • – |
2022-12-23 |
4 |
B |
$0.35 |
$87,875 |
D/D |
250,000 |
532,049 |
2.39 |
-31% |
|
| Kingsley Alfred D |
Director |
– • – |
2022-12-22 |
4 |
B |
$0.29 |
$7,125 |
D/D |
25,000 |
439,111 |
2.39 |
-9% |
|
| Ross Douglas T. |
Former CSO |
• – – |
2022-12-21 |
4 |
A |
$0.00 |
$0 |
D/D |
213,797 |
234,114 |
|
- |
|
| Riggs Josh |
Interim CEOOfficer |
• – – |
2022-12-02 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
2,308 |
|
-36% |
|
| Ross Douglas T. |
Former CSO. |
• – – |
2022-12-01 |
4 |
D |
$0.00 |
$0 |
D/D |
(150,000) |
20,317 |
|
- |
|
| Paulsen Gisela |
Former President and COO |
• – – |
2022-12-01 |
4 |
D |
$0.00 |
$0 |
D/D |
(175,000) |
366,500 |
|
- |
|
142 Records found
|
|
Page 1 of 6 |
|
|
